“…There is converging evidence that stimulating astrocytes pharmacologically, or ablating astrocytes with gliotoxins, reveals purinergic-dependent, glial-derived modulation of the spinal cord locomotor CPG (Dale and Gilday, 1996;Dale, 1998;Brown and Dale, 2000;Witts et al, 2012Witts et al, , 2015Acton and Miles, 2015;Acevedo et al, 2016;Acton and Miles, 2017;Acton et al, 2018;Rivera-Oliver et al, 2018). Although astrocytes in other CNS regions demonstrate the ability to utilize other transmitters, such as glutamate or GABA (Malarkey and Parpura, 2008;Christensen et al, 2018); there is a paucity of evidence to suggest that other gliotransmitters are involved in the astrocytic control of the locomotor CPG. In previous studies, antagonists of purinergic signaling were sufficient to block all the astrocytic effects on the locomotor network (Acton and Miles, 2015;Witts et al, 2015;Acton and Miles, 2017;Acton et al, 2018).…”